
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
ANKARA, Turkey, Sept 25, 2024 – (ACN Newswire via SeaPRwire.com) – GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced […]